Diagnosis: Acute generalized exanthematous pustulosis (AGEP)
A 34-year-old female presented with an acute eruption of tiny, sterile pustules localized primarily in the flexural areas. The patient reported recent exposure to a new medication, and the examination revealed characteristic pustular lesions alongside systemic symptoms. This case illustrates the importance of recognizing cutaneous adverse drug reactions.
A 34-year-old female presented with a 5-day history of an acute eruption of tiny, sterile pustules primarily affecting the flexural regions, accompanied by fever and malaise. On examination, the skin revealed numerous superficial pustules on an erythematous base, predominantly in the axillary and groin areas. The lesions were non-follicular and surrounded by erythema, with no associated vesicles or crusting.Distribution: Pustules concentrated in flexural areas and intertriginous zones.Associated symptoms: Systemic symptoms including fever and malaise.Lesion characteristics: Non-follicular pustules with an erythematous base.Absence of systemic infection: No signs of bacterial infection or other dermatoses.
The onset of the lesions was noted 4 days after the initiation of a new medication for hypertension. The patient denied any recent infections or travel history. She has a past medical history of hypertension and no known drug allergies. Family history was unremarkable for skin disorders. Socially, she works as a nurse and has no significant exposure to irritants or allergens.Onset: Lesions appeared 4 days post medication initiation.Triggers: Recent exposure to a new antihypertensive medication.Past medical history: Hypertension, no known drug allergies.Family history: Unremarkable for dermatological conditions.Social history: No exposure to irritants; works as a nurse.
Acute / First-Line ManagementImmediate discontinuation of the offending medication is crucial.Supportive care includes topical corticosteroids (e.g., clobetasol propionate 0.05% cream applied twice daily) to reduce inflammation.Oral prednisone can be considered for severe cases; a typical regimen is 1 mg/kg/day for 5-10 days, tapering thereafter.Workup and Diagnostic ConfirmationClinical diagnosis is typically sufficient; however, a skin biopsy may be performed to rule out other conditions.Laboratory tests can include a complete blood count to assess for leukocytosis, which may suggest an inflammatory response.Patch testing may be useful in cases with unclear medication triggers.Long-Term ManagementEducate the patient on avoiding the identified trigger and similar medications in the future.Follow-up care should include monitoring for potential recurrence and managing any residual skin changes.Consider referral to a dermatologist for persistent or severe cases to optimize management.
Psoriasis: Characterized by well-defined erythematous plaques with silvery scales, typically not presenting as pustules in flexural areas.Impetigo: Commonly presents with pustules and crusting, often associated with bacterial infection, which can be confirmed by culture.Folliculitis: Involves pustules around hair follicles, often with pruritus, and can be differentiated by the presence of hair follicles in the lesions.Drug reaction with eosinophilia and systemic symptoms (DRESS): Associated with systemic involvement and eosinophilia, typically with a longer onset compared to AGEP.Acneiform eruptions: Presents with papules and pustules but typically involves the face and trunk, not isolated to flexural areas.Subcorneal pustular dermatosis: Characterized by sterile pustules, often in flexural areas, but usually presents with a chronic course.Viral exanthems: Often associated with systemic symptoms and different lesion morphology, typically not presenting as pustules.
High-Yield PearlsRecognition: AGEP typically presents with acute pustular eruptions following drug exposure.Diagnosis: Diagnosis is primarily clinical, based on the characteristic pustular morphology and distribution.Management: Discontinuation of the offending agent is the cornerstone of treatment.Systemic symptoms: Accompanying systemic symptoms such as fever often help in distinguishing AGEP from localized pustular conditions.Follow-up: Monitoring for potential complications or recurrence is essential in management.Understanding drug reactions is vital for timely diagnosis and management of AGEP, a potentially severe condition.
Tags: AGEP, drug reaction